STOCK TITAN

Becton Dickinson & Co. - BDX STOCK NEWS

Welcome to our dedicated news page for Becton Dickinson & Co. (Ticker: BDX), a resource for investors and traders seeking the latest updates and insights on Becton Dickinson & Co..

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Becton Dickinson & Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Becton Dickinson & Co.'s position in the market.

Rhea-AI Summary
Revelyst appoints Joe Beck as Chief Supply Chain Officer to lead business transformation and efficiency efforts. Beck brings extensive experience in global supply chain operations and logistics, with a proven track record of success. His strategic vision aligns with Revelyst's goal of becoming the industry's top brands house, driving growth and innovation. Beck's appointment signals a pivotal moment for Revelyst as it restructures its business model and invests in high-potential brands for accelerated growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) receives the Business Group on Health 'Best Employers: Excellence in Health & Well-being Award' for its commitment to employee well-being. The company also earns honors for 'Excellence in Global Health & Well-being' for its diverse benefits offerings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
-
Rhea-AI Summary
BD announces the global commercial release of the new BD FACSDiscover™ S8 Cell Sorters featuring BD CellView™ Image Technology and BD SpectralFX™ Technology, offering breakthrough innovations in real-time imaging and spectral flow cytometry. Researchers in various fields can now access greater flexibility and options to incorporate this technology in their labs, enabling them to confirm complex biological insights, obtain individual cell images, and isolate desired cells based on visual characteristics at high speeds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
Rhea-AI Summary
BD (Becton, Dickinson and Company) will report financial results for its second quarter of fiscal year 2024 on May 2, 2024. The news release will include summary financial information for the quarter ending on March 31, 2024. BD management will host an audio webcast to discuss financial results, operations, and strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) unveils survey results revealing patient concerns over repetitive needlesticks during hospital procedures. The survey, conducted by The Harris Poll, shows that many Americans are unaware of the risks associated with common medical procedures, with over half fearing multiple needle insertions. Nurses also express concerns over the negative impact of repeated needlesticks on patient care delivery and workflow.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
none
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) has been recognized for its innovation by being named to Fortune's 2024 list of America's Most Innovative Companies. This acknowledgment highlights BD's commitment to driving advancements in medical technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
none
Rhea-AI Summary
BD (Becton, Dickinson and Company) responds to the FDA Safety Communication regarding plastic syringes by increasing U.S. production to meet demand. The company assures the safety and quality of its products, emphasizing its commitment to supporting the healthcare system and patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
-
Rhea-AI Summary
BD (Becton, Dickinson and Company) partners with Danish health care institutions to recycle used blood collection tubes, reducing environmental impact. The innovative method involves cleaning and recycling PET plastic tubes, diverting 33 tonnes of plastic from incineration annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
-
News
Rhea-AI Summary
Zeus, a leading polymer extrusion and catheter design manufacturer, appoints Padraic 'Paddy' O'Brien as the new CEO. O'Brien, currently the Worldwide President of BD Peripheral Intervention, brings a wealth of experience to lead Zeus under EQT ownership. The company aims for growth and innovation in the medical device industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
Rhea-AI Summary
BD (Becton, Dickinson and Company) announces positive results from a study on automated dispensing cabinets in long-term care facilities. The study shows significant improvements in medication retrieval time, cost savings, and workflow efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
Becton Dickinson & Co.

NYSE:BDX

BDX Rankings

BDX Stock Data

66.74B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Franklin Lakes

About BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.